Pivot Signs Exclusive Manufacturing Agreement with Bio V Pharma Inc. |
May 30, 2018 | May 2018 Bond Updates |
Bio-Cannabis Product Pipeline Ready To Be Commercialized In Canada
VANCOUVER, May 30, 2018 /PRNewswire/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed an exclusive Contract Manufacturing... |
View more at: https://www.prnewswire.com/news-releases/pivot-signs-exclusive-manufacturing-agreement-with-bio-v-pharma-inc-300656208.html |
Related News |